SPP100
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SPP100, covering 2006-07-28 to 2016-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension [Phase 3]